340B Hospitals Ask Judge to Stop Part B Drug Payment Cuts Immediately

hypodermic needle and glass ampule
Groups that represent 340B hospitals asked a federal district judge to immediately halt a nearly 30% Medicare Part B payment cut for hospitals’ 340B-purchased drugs.

Groups that represent 340B hospitals yesterday asked a federal district judge in Washington, D.C., to immediately halt a nearly 30% Medicare Part B payment cut in place since 2018 for hospitals’ 340B-purchased drugs.

American Hospital Association, America’s Essential Hospitals, Association

Read More »

Purdue Pharma Is Providing 340B Refunds Spanning 16 Years of Overcharges

A bottle of Betasept antiseptic scrub
Purdue Pharma announced refunds for 340B overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—more than half of the 340B program's existence.

Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021. That period covers more than half of the 340B program’s existence.

During

Read More »

Senate Democrats Say They Are on Track to Pass Drug Pricing Bill Before Aug. 8

U.S. Senate chamber viewed from public gallery
Senate Democrats are still pushing to pass drug pricing legislation before the chamber begins its summer break on Aug. 8.

Senate Democrats said yesterday they would know this week whether an updated Senate drug pricing bill meets the criteria for passage via budget reconciliation, which requires just 50 Democratic votes. The bill remains on track for a floor vote before

Read More »

HRSA Unveils New 340B Contract Pharmacy Services Webpage That Is Silent on Manufacturer Obligations

screenshot of HRSA contract pharmacy services
HRSA has posted a new 340B Contract Pharmacy Services webpage that addresses requirements for covered entities but not for pharmaceutical manufacturers.

The U.S. Health Resources and Services Administration overnight unveiled a new Contract Pharmacy Services page on the 340B program website that addresses requirements for covered entities but not for pharmaceutical manufacturers.

The webpage links to HRSA’s 2010 contract pharmacy final

Read More »

A Blizzard in July (of Briefs in 340B Contract Pharmacy Lawsuits)

office worker holding a stack of papers
Multiple briefs have been filed recently in federal appellate lawsuits over the government's enforcement ability with the 340B contract pharmacy program.

There’s been a burst of activity in federal appellate lawsuits over the legality of drug manufacturers’ conditions on 340B pricing involving contract pharmacies.

During the past two weeks, AstraZeneca, Lilly, Novo Nordisk, and Sanofi filed briefs restating their belief that

Read More »

Hospitals Want Expedited Order Stopping Medicare Payment Cuts for 340B Drugs 

patient receiving an IV infusion
340B hospitals want an expedited court order stopping CMS from "unlawfully underpaying for 340B drugs."

Hospital groups and health systems asked a federal appeals court on Monday to send their successful U.S. Supreme Court lawsuit over Medicare Part B reimbursement cuts for 340B drugs back to a district court for more proceedings. “The government does

Read More »

Biden Administration Kills Trump-era Rules Casting Doubt on HHS Guidance and Enforcement Actions

hand dropping crumpled paper into metal mesh wastebasket
The Biden administration repealed Trump-era rules that it said hindered HHS from issuing guidance and bringing enforcement actions.

The Biden administration yesterday repealed Trump administration final rules that it said hindered the U.S. Health and Human Services Department’s (HHS) ability “to issue guidance, bring enforcement actions, and take other appropriate actions that advance the department’s mission.”

Under ex-President

Read More »

340B Report Publisher and CEO: What to Expect Following Midterm Elections

A roll of I Voted, Yo Vote stickers
Look for the GOP to try again to put more restrictions on the 340B program if the party takes over the U.S. House, 340B Report Publisher and CEO Ted Slafsky says.

Congress’ attitude toward the 340B program will likely change in 2023 and 2024 because of November’s midterm election results, 340B Report Publisher and CEO Ted Slafsky predicts in his latest column for Omnicell.

It is customary for the party that

Read More »

U.S. Supreme Court Formally Notifies Lower Court and Parties About its Decision Striking Down Medicare Part B Drug Payment Cuts for 340B Hospitals

The Supreme Court of the United States building
Major hospital groups have asked the Supreme Court to review a case that challenges HHS' DSH payment formula.

The clerk of the U.S. Supreme Court on Monday formally notified the clerk of a federal appeals court in Washington, D.C., and lawyers for three hospital groups and three health systems of the high court’s June 15 judgement in the

Read More »

Senate Democrats Optimistic About Passing Drug Pricing Bill Before August Recess

Rachel Cohrs and Sen. Ron Wyden headshots
Senate Finance Chair Ron Wyden (right) said yesterday during a webinar moderated by STAT correspondent Rachel Cohrs (left) that Senate Democrats want to pass drug pricing legislation "right now, before everybody leaves for August."

U.S. Senate Democrats are hopeful that drug pricing legislation will be passed by early next month via a budget reconciliation process requiring just 50 Democratic votes, a Democratic source with knowledge of the process told 340B Report.

“Our expectation is, we’re

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live